Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study - Abe, Shinya; Kawai, Kazushige; Nozawa, Hiroaki; Sasaki, Kazuhito; Murono, Koji; Emoto, Shigenobu; Ozawa, Tsuyoshi; Yokoyama, Yuichiro; Nagai, Yuzo; Anzai, Hiroyuki; Sonoda, Hirofumi; Yamauchi, Shinichi; et al. (BMC Cancer, 2022)
Keywords: Adenocarcinoma; Antigens; Cancer therapies; Cecum; Chemoradiotherapy; Chemotherapy; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms; Colorectal Neoplasms - drug therapy; Colorectal Neoplasms - pathology; Colorectal Neoplasms - surgery; Drug therapy; Evaluation; Female; Females; Humans; Liver; Lymph nodes; Lymphatic Metastasis; Lymphatic system; Male; Males; Medical prognosis; Metastases; Metastasis; Mutation; Neoplasm Recurrence, Local; Neoplasm Recurrence, Local - epidemiology; Neoplasm Recurrence, Local - pathology; Neoplasm Staging; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; Outcome; Patients; Peritoneum; Physiological aspects; Primary tumor location; Prognosis; Prognostic marker; Radiation therapy; RC254-282; Retrospective Studies; Review boards; Sex; Sex factors in disease; Surgery; Surveillance; Survival; Tumors; Japan; Primary tumor location; Chemoradiotherapy; Outcome; Prognostic marker; Colorectal cancer